Showing results (11-20 of 596) with videos related to
Sort By:
Pageof 60
Clinical Neuropharmacology|January 1, 1990
Are biochemical markers for treatment-resistant schizophrenia state dependent or traits?D P van Kammen, N SchoolerLife Sciences|April 9, 1984
Impaired noradrenergic transmission in schizophrenia?D P van Kammen, S AntelmanJournal of Homosexuality|January 1, 1977
Erotic imagery and self-castration in transvestism/transsexualism: a case reportD P van Kammen, J MoneySchizophrenia Research|March 1, 1991
Dopamine and norepinephrine activity in schizophrenia. An integrative perspectiveD P van Kammen, M KelleyProstaglandins, Leukotrienes, and Essential Fatty Acids|August 1, 1996
Incorporation of 3H-arachidonic acid into platelet phospholipids of patients with schizophreniaJ K Yao, D P van KammenJournal of Neural Transmission|January 1, 1985
d-Amphetamine raises cortisol levels in schizophrenic patients with and without chronic naltrexone pretreatmentD P van Kammen, S C SchulzBiological Psychiatry|October 6, 1997
Recent and remote memory dissociation: medication effects and hippocampal function in schizophreniaM W Gilbertson, D P van KammenArchives of General Psychiatry|March 1, 1983
alpha-Adrenergic receptor function in schizophrenia. Receptor number, cyclic adenosine monophosphate production, adenylate cyclase activity, and effect of drugsM S Kafka, D P van KammenSchizophrenia Research|February 1, 1994
Red blood cell membrane dynamics in schizophrenia. I. Membrane fluidityJ K Yao, D P van KammenThe American Journal of Psychiatry|June 1, 1983
Platelet MAO activity and long-term outcome in schizophrenia and schizoaffective disorderK L Malas, D P van KammenPageof 60